Clinical Trial Detail

NCT ID NCT01938638
Title Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

triple-receptor negative breast cancer

diffuse large B-cell lymphoma

stomach cancer

Therapies

BAY1143572

Age Groups: adult

No variant requirements are available.